Schedule 13G ownership disclosure

Millendo Therapeutics, Inc.

Security class unavailable · CUSIP: 60040X103

Event date: 2018-12-07

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,285,068
Percent of class
9.9500%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000930413-18-003561
Form type
SC 13G
Filer
GREAT POINT PARTNERS LLC
CIK
CIK 1281446
Filed
Dec 17, 2018
Reporting period
Dec 07, 2018
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub